London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Motif up 2percent. Amp 15 percent.
Expecting similar type on the news
Rise 'cause we are worth 10m Mcap based on 8.8% holding, and current Mcap is 3.8m!
All those debts were factored in by the market @0.57p!
Enough said!
Roll on Approval of MRSA resistant antibiotic! AKA Iclaprim!
Current mcap vs current debt? Mmm not sure how you get that one liquid Share price “factoring it in” isn’t correct. Look at mcap and debt which is more accurate of over or under valued in my eyes The biggest rise with be on motif imo But I’m in both so makes no odds as long as approved
We are the largest shareholder of polx owning 23% which equates to 3.9m. Now look at the market cap!!
Nothing in the market makes sense! Just go with the flow!
It’s 18% but that’s just splitting hairs. We also own £10million worth of Motif at today’s prices.
And the others are on the books maybe up to a couple of million.
So that adds up to fag pack maths of around £15million worth of investments AMP. Have.
That’s what people are looking at. The problem is they don’t delve deep enough to see AMP. Might have £15m worth or investments. They also have around £27 million debt. This could still multibag. IF Motif 3 bags or more. Work it out. It’s still definitely worth a punt if you believe Motif will multibag.
Debt is around 22m.
At mtfb = 70p (200m mcap) - amp is debt free.
All very positive
Gl
It’s not “debt free” until all debts and loans paid off. Simples Assets would need to be sold
Amphion's interims (view the detailed financial report addendum 10..), total liabilities are $29,053,470 (£22.44m) that includes convertible promissory notes, promissory notes, and several loan facilities. This figure excludes monies owed to the directors of $4.5m (£3.48m). If you then add the directors' monies to the £22.44m you arrive at £25.92m. Now, applying mandatory routine fiscal adjustments (cash burn and interest payments on the liabilities) gives a projected debt value of £27.4m.
I think this number crunching is rather pointless at this stage as let’s be real - if motif get FDA approval, a lot of people will be buying into both and will hoping to get on a nice spike and bail out with decent profit. Once that RNS comes through, if good, the sp here will rise a fair amount. The MMs won’t get their pen and papers out and calculate how much debt etc they have and think “ah okay great RNS at Motif, let’s keep it as 1.8 because that balances their books”. Market dynamics will play its role and its going to go up here if there’s good news, we just don’t know by how much.
All fingers crossed for Motif multibagging. This with leverage will give us a much greater advantage if it 3 bags or more. It’s worrh a punt. If it doesn’t get approval AMP are totally screwed. But looks like Motif are confident.
Motif shares in the US are starting to tick up.
Spot on DP
The accountants do things differently. Waiting for an entry at 1.7p probably.
Tomorrow pre-rns is last chance to buy cheap. Sure to be some shaking.
If RNS lands and it's approval, don't plan to buy in the 1s. And certainly not when MTFB is at 114p lol Good joke
You’ve all had over a week the dissect the figures and what ? Total liabilities but then add in directors loans to justify your figure. Joke. Total is total. 8m of liabilities is CPNs at 3 p so they won’t be repaid in cash so it’s not debt. But Dilution , yes. Peeps throwing cash around without reading ( or understanding) the financials. This is a long termer at 1 p ( with risk of course) but very considerable upside indeed if you think iclipram smahes the market - which being a non resistant AB - it’s very likely. And POLX looks good but later BB as per , v little proper analysis .
Assumption that others don't understand the numbers here is a little patronising.
There is a stark difference between liabilities and current liabilities. If you don't understand watch the SP over the next week following (hopefully) MTFB approval, and sit down and acknowledge that you don't understand.
Aviz, care to elaborate on your understanding in that case?
Nope......DYOR
Binary.
FDA yes or no. Yes....moon. No.....in the pits. Take you're pick.
Gut will be telling you either or, has nothing to do with current or non current liabilities. MM project fear.
Total liabilities are current liabilities. The stark difference is nil . ( easy to check) You ain’t checked anything. 8m CPNs - what does that do to SP? A bb is for investors who discuss the highs and lows over the medium term. You don’t understand the numbers. Your praying for a spike. Fair dos, just don’t pump crap.